Bioventus Inc (BVS) — Capital Reinvestment Ratio
Bioventus Inc (BVS) has a Capital Reinvestment Ratio of 0.05x as of June 2026, meaning it reinvests 0% of its operating cash flow ($19.87 Million) in capital expenditures ($960.00K). Check BVS intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bioventus Inc Capital Reinvestment Ratio (2013–2025)
This chart tracks Bioventus Inc's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see BVS cash flow conversion.
Annual Capital Reinvestment Ratio for Bioventus Inc (2013–2025)
Year-by-year Capital Reinvestment Ratio for Bioventus Inc from 2013 to 2025. See BVS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | $73.98 Million | $2.56 Million | ▲ +33.6% |
| 2024 | 0.03x | $38.80 Million | $1.01 Million | ▼ -94.6% |
| 2023 | 0.48x | $15.34 Million | $7.36 Million | ▲ +49.7% |
| 2021 | 0.32x | $22.99 Million | $7.37 Million | ▲ +11.3% |
| 2020 | 0.29x | $71.80 Million | $20.67 Million | ▲ +40.5% |
| 2019 | 0.20x | $40.71 Million | $8.34 Million | ▲ +52.8% |
| 2018 | 0.13x | $45.19 Million | $6.06 Million | ▼ -65.9% |
| 2015 | 0.39x | $18.92 Million | $7.44 Million | ▼ -71.5% |
| 2014 | 1.38x | $15.11 Million | $20.83 Million | ▼ -40.4% |
| 2013 | 2.31x | $2.75 Million | $6.36 Million | — |